These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33017618)

  • 1. Hsp90 regulates HDAC3-dependent gene transcription while HDAC3 regulates the functions of Hsp90.
    Kotwal A; Amere Subbarao S
    Cell Signal; 2020 Dec; 76():109801. PubMed ID: 33017618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitors prevent pulmonary endothelial hyperpermeability and acute lung injury by regulating heat shock protein 90 function.
    Joshi AD; Barabutis N; Birmpas C; Dimitropoulou C; Thangjam G; Cherian-Shaw M; Dennison J; Catravas JD
    Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(12):L1410-9. PubMed ID: 26498249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A duplexed phenotypic screen for the simultaneous detection of inhibitors of the molecular chaperone heat shock protein 90 and modulators of cellular acetylation.
    Hardcastle A; Tomlin P; Norris C; Richards J; Cordwell M; Boxall K; Rowlands M; Jones K; Collins I; McDonald E; Workman P; Aherne W
    Mol Cancer Ther; 2007 Mar; 6(3):1112-22. PubMed ID: 17363504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaffold dependent histone deacetylase (HDAC) inhibitor induced re-equilibration of the subcellular localization and post-translational modification state of class I HDACs.
    Hanigan TW; Taha TY; Aboukhatwa SM; Frasor J; Petukhov PA
    PLoS One; 2017; 12(10):e0186620. PubMed ID: 29045501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugging the HDAC6-HSP90 interplay in malignant cells.
    Krämer OH; Mahboobi S; Sellmer A
    Trends Pharmacol Sci; 2014 Oct; 35(10):501-9. PubMed ID: 25234862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDAC3 is a critical negative regulator of long-term memory formation.
    McQuown SC; Barrett RM; Matheos DP; Post RJ; Rogge GA; Alenghat T; Mullican SE; Jones S; Rusche JR; Lazar MA; Wood MA
    J Neurosci; 2011 Jan; 31(2):764-74. PubMed ID: 21228185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttranslational modification and beyond: interplay between histone deacetylase 6 and heat-shock protein 90.
    Liu P; Xiao J; Wang Y; Song X; Huang L; Ren Z; Kitazato K; Wang Y
    Mol Med; 2021 Sep; 27(1):110. PubMed ID: 34530730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CG0006, a novel histone deacetylase inhibitor, induces breast cancer cell death via histone-acetylation and chaperone-disrupting pathways independent of ER status.
    Kim HM; Kim CS; Lee JH; Jang SJ; Hwang JJ; Ro S; Hyun YL; Choi J
    Breast Cancer Res Treat; 2011 Nov; 130(2):365-75. PubMed ID: 21184271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and biologic analysis of histone deacetylase inhibitors with diverse specificities.
    Newbold A; Matthews GM; Bots M; Cluse LA; Clarke CJ; Banks KM; Cullinane C; Bolden JE; Christiansen AJ; Dickins RA; Miccolo C; Chiocca S; Kral AM; Ozerova ND; Miller TA; Methot JL; Richon VM; Secrist JP; Minucci S; Johnstone RW
    Mol Cancer Ther; 2013 Dec; 12(12):2709-21. PubMed ID: 24092806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deacetylase-independent function of HDAC3 in transcription and metabolism requires nuclear receptor corepressor.
    Sun Z; Feng D; Fang B; Mullican SE; You SH; Lim HW; Everett LJ; Nabel CS; Li Y; Selvakumaran V; Won KJ; Lazar MA
    Mol Cell; 2013 Dec; 52(6):769-82. PubMed ID: 24268577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.
    Bali P; Pranpat M; Bradner J; Balasis M; Fiskus W; Guo F; Rocha K; Kumaraswamy S; Boyapalle S; Atadja P; Seto E; Bhalla K
    J Biol Chem; 2005 Jul; 280(29):26729-34. PubMed ID: 15937340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitotic Activation of a Novel Histone Deacetylase 3-Linker Histone H1.3 Protein Complex by Protein Kinase CK2.
    Patil H; Wilks C; Gonzalez RW; Dhanireddy S; Conrad-Webb H; Bergel M
    J Biol Chem; 2016 Feb; 291(7):3158-72. PubMed ID: 26663086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells.
    Wang H; Fu C; Du J; Wang H; He R; Yin X; Li H; Li X; Wang H; Li K; Zheng L; Liu Z; Qiu Y
    J Exp Clin Cancer Res; 2020 Feb; 39(1):29. PubMed ID: 32024543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I pharmacokinetic and pharmacodynamic study of LAQ824, a hydroxamate histone deacetylase inhibitor with a heat shock protein-90 inhibitory profile, in patients with advanced solid tumors.
    de Bono JS; Kristeleit R; Tolcher A; Fong P; Pacey S; Karavasilis V; Mita M; Shaw H; Workman P; Kaye S; Rowinsky EK; Aherne W; Atadja P; Scott JW; Patnaik A
    Clin Cancer Res; 2008 Oct; 14(20):6663-73. PubMed ID: 18927309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbamazepine promotes Her-2 protein degradation in breast cancer cells by modulating HDAC6 activity and acetylation of Hsp90.
    Meng Q; Chen X; Sun L; Zhao C; Sui G; Cai L
    Mol Cell Biochem; 2011 Feb; 348(1-2):165-71. PubMed ID: 21082217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDACs and HDAC Inhibitors in Cancer Development and Therapy.
    Li Y; Seto E
    Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27599530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone acetylation and the cell-cycle in cancer.
    Wang C; Fu M; Mani S; Wadler S; Senderowicz AM; Pestell RG
    Front Biosci; 2001 Apr; 6():D610-29. PubMed ID: 11282573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxamic acid analogue histone deacetylase inhibitors attenuate estrogen receptor-alpha levels and transcriptional activity: a result of hyperacetylation and inhibition of chaperone function of heat shock protein 90.
    Fiskus W; Ren Y; Mohapatra A; Bali P; Mandawat A; Rao R; Herger B; Yang Y; Atadja P; Wu J; Bhalla K
    Clin Cancer Res; 2007 Aug; 13(16):4882-90. PubMed ID: 17699868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid Enzalutamide Derivatives with Histone Deacetylase Inhibitor Activity Decrease Heat Shock Protein 90 and Androgen Receptor Levels and Inhibit Viability in Enzalutamide-Resistant C4-2 Prostate Cancer Cells.
    Rosati R; Chen B; Patki M; McFall T; Ou S; Heath E; Ratnam M; Qin Z
    Mol Pharmacol; 2016 Sep; 90(3):225-37. PubMed ID: 27382012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.